FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors Joseph Mallon, Ph.D. & Susan M. Janicki, Ph.D. The Expedited Investigational New Drug (IND) Pilot…
Scientifically Impossible Claims – Not Indefinite, But Not Enabled Douglas B. Wentzel The Federal Circuit held that scientifically impossible-to-perform claims were not indefinite but were invalid for lack of enablement….
IRVINE, Calif., October 23, 2026 – Knobbe Martens is pleased to share that partners Sabing Lee, Salima Merani, Ph.D., and Joseph Re have been featured in the 2027 IAM Global…
In a recent article published in IPWatchdog, Knobbe Martens’ Design Patent Litigation Practice Chair Ben Katzenellenbogen examines issues that can arise from overlapping trade dress and design patent rights. He…
In a recent article published in the Journal of Intellectual Property & Technology Law, Knobbe Martens partners Ari Feinstein and Charlene Azema explore strategies for asserting and defending against lack-of-bona…
September Federal Circuit Newsletter (Japanese) September Federal Circuit Newsletter (Chinese) Silent Reference, Loud Expert: PTAB May Rely on Expert Testimony to Show How Reference Discloses a Missing Limitation In…
IRVINE, Calif., October 13, 2026 – Knobbe Martens has been shortlisted as among the country’s most innovative law firms at the 2026 Financial Times Innovative Lawyers North America Awards. The…
In a recent IAM article on the latest developments in a trade secrets dispute between software company Zync and automotive manufacturer BMW, Knobbe Martens’ ITC Litigation Practice Co-Chair Sheila Swaroop…
Knobbe Martens litigation partner Irfan Lateef was quoted in the IAM article, “U.S. Federal Circuit Raises Stakes for Patent Claim Drafting in Satius Ruling,” discussing the importance of preparing patent…
In their latest Law360 column examining noteworthy IP decisions at the Federal Circuit, Knobbe Martens partners Sean Murray and Jeremiah Helm discuss VDPP LLC v. Volkswagen Group of America Inc….